FN1 and cancer: Cancer-associated fibroblasts (CAFs) can remodel the ECM by secreting large amounts of collagen and fibronectin, creating barriers that hinder the penetration of drugs and immune cells into tumors, thereby reducing treatment efficacy (Biffi and Tuveson, 2021).